Analysis Life Sciences Thank You What We Expect the FDA to do in December 2023
Agency IQ
DECEMBER 1, 2023
to provide notice and an opportunity for owners or consignees of the drug to appear before the Agency and introduce testimony prior to the destruction of their drug. and Annex 1 Conference Joel Welch December 12 AgencyIQ Looking ahead to 2024: Regulatory Forecast for the U.S. to include devices.
40 
Let's personalize your content